Nxera Pharma Settles Patent Infringement Case for miniG Platform
Nxera Pharma Co., Ltd. announced that its UK unit has settled a patent infringement case brought by OMass Therapeutics concerning its miniG platform. The terms of the settlement are confidential, and the case in the Patents Court of England and Wales is now resolved.